Neurostimulation Devices Market Size, Growth Opportunity 2034

Neurostimulation Devices Market Size - By Product, By Type, By Application, By End Use, Growth Forecast, 2025 - 2034

Report Content

Chapter 1&nbsp;&nbsp;&nbsp;Methodology and Scope

1.1&nbsp;&nbsp;&nbsp; Market scope and definitions

1.2&nbsp;&nbsp;&nbsp; Research design

1.2.1&nbsp;&nbsp;&nbsp; Research approach

1.2.2&nbsp;&nbsp;&nbsp; Data collection methods

1.3&nbsp;&nbsp;&nbsp; Data mining sources

1.3.1&nbsp;&nbsp;&nbsp; Global

1.3.2&nbsp;&nbsp;&nbsp; Regional/Country

1.4&nbsp;&nbsp;&nbsp; Base estimates and calculations

1.4.1&nbsp;&nbsp;&nbsp; Base year calculation

1.4.2&nbsp;&nbsp;&nbsp; Key trends for market estimation

1.5&nbsp;&nbsp;&nbsp; Primary research and validation

1.5.1&nbsp;&nbsp;&nbsp; Primary sources

1.6&nbsp;&nbsp;&nbsp; Forecast model

1.7&nbsp;&nbsp;&nbsp; Research assumptions and limitations

Chapter 2&nbsp;&nbsp;&nbsp;Executive Summary

2.1&nbsp;&nbsp;&nbsp; Industry 3600 synopsis

2.2&nbsp;&nbsp;&nbsp; Key market trends

2.2.1&nbsp;&nbsp;&nbsp; Regional

2.2.2&nbsp;&nbsp;&nbsp; Product

2.2.3&nbsp;&nbsp;&nbsp; Type

2.2.4&nbsp;&nbsp;&nbsp; Application

2.2.5&nbsp;&nbsp;&nbsp; End Use

2.3&nbsp;&nbsp;&nbsp; CXO perspectives: Strategic imperatives

2.3.1&nbsp;&nbsp;&nbsp; Key decision points for industry executives

2.3.2&nbsp;&nbsp;&nbsp; Critical success factors for market players

2.4&nbsp;&nbsp;&nbsp; Future outlook and strategic recommendations

Chapter 3&nbsp;&nbsp;&nbsp;Industry Insights

3.1&nbsp;&nbsp;&nbsp; Industry ecosystem analysis

3.2&nbsp;&nbsp;&nbsp; Industry impact forces

3.2.1&nbsp;&nbsp;&nbsp; Growth drivers

3.2.1.1&nbsp;&nbsp;&nbsp; Increasing demand for minimally invasive surgery in developed countries

3.2.1.2&nbsp;&nbsp;&nbsp; Increasing prevalence of neurological disorders

3.2.1.3&nbsp;&nbsp;&nbsp; Technological advancements in neurostimulation devices

3.2.1.4&nbsp;&nbsp;&nbsp; Increasing number of elderly patients with neurological disorders

3.2.1.5&nbsp;&nbsp;&nbsp; Investments by companies and organizations across the globe

3.2.2&nbsp;&nbsp;&nbsp; Industry pitfalls and challenges

3.2.2.1&nbsp;&nbsp;&nbsp; Complications associated with neurostimulation devices

3.2.2.2&nbsp;&nbsp;&nbsp; Lack of skilled healthcare practitioners

3.2.3&nbsp;&nbsp;&nbsp; Market opportunities

3.2.3.1&nbsp;&nbsp;&nbsp; Integration with digital health and AI

3.3&nbsp;&nbsp;&nbsp; Growth potential analysis

3.4&nbsp;&nbsp;&nbsp; Regulatory landscape

3.4.1&nbsp;&nbsp;&nbsp; North America

3.4.2&nbsp;&nbsp;&nbsp; Europe

3.4.3&nbsp;&nbsp;&nbsp; Asia Pacific

3.4.4&nbsp;&nbsp;&nbsp; Latin America

3.4.5&nbsp;&nbsp;&nbsp; Middle East and Africa

3.5&nbsp;&nbsp;&nbsp; Technology landscape

3.6&nbsp;&nbsp;&nbsp; Future market trends

3.7&nbsp;&nbsp;&nbsp; Gap analysis

3.8&nbsp;&nbsp;&nbsp; Pricing analysis

3.9&nbsp;&nbsp;&nbsp; Reimbursement scenario

3.10&nbsp;&nbsp;&nbsp; Porter&rsquo;s analysis

3.11&nbsp;&nbsp;&nbsp; PESTEL analysis

Chapter 4&nbsp;&nbsp;&nbsp;Competitive Landscape, 2024

4.1&nbsp;&nbsp;&nbsp; Introduction

4.2&nbsp;&nbsp;&nbsp; Company market share analysis

4.3&nbsp;&nbsp;&nbsp; Company matrix analysis

4.4&nbsp;&nbsp;&nbsp; Competitive analysis of major market players

4.5&nbsp;&nbsp;&nbsp; Competitive positioning matrix

4.6&nbsp;&nbsp;&nbsp; Strategy dashboard

4.7&nbsp;&nbsp;&nbsp; Key developments

4.7.1&nbsp;&nbsp;&nbsp; Mergers and acquisitions

4.7.2&nbsp;&nbsp;&nbsp; Partnerships and collaborations

4.7.3&nbsp;&nbsp;&nbsp; New product launches

4.7.4&nbsp;&nbsp;&nbsp; Expansion plans

Chapter 5&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Product, 2021 - 2034 ($ Mn)

5.1&nbsp;&nbsp;&nbsp; Key trends

5.2&nbsp;&nbsp;&nbsp; Spinal cord stimulator

5.3&nbsp;&nbsp;&nbsp; Deep brain stimulator

5.4&nbsp;&nbsp;&nbsp; Sacral nerve stimulator

5.5&nbsp;&nbsp;&nbsp; Vagus nerve stimulator

5.6&nbsp;&nbsp;&nbsp; Gastric electric stimulator

5.7&nbsp;&nbsp;&nbsp; Transcutaneous electrical nerve stimulation (tens)

5.8&nbsp;&nbsp;&nbsp; Other products

Chapter 6&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Type, 2021 - 2034 ($ Mn)

6.1&nbsp;&nbsp;&nbsp; Key trends

6.2&nbsp;&nbsp;&nbsp; Invasive

6.3&nbsp;&nbsp;&nbsp; Non-invasive

Chapter 7&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Application, 2021 - 2034 ($ Mn)

7.1&nbsp;&nbsp;&nbsp; Key trends

7.2&nbsp;&nbsp;&nbsp; Pain management

7.3&nbsp;&nbsp;&nbsp; Urinary and fecal incontinence

7.4&nbsp;&nbsp;&nbsp; Parkinson&#39;s disease

7.5&nbsp;&nbsp;&nbsp; Epilepsy

7.6&nbsp;&nbsp;&nbsp; Essential tremor

7.7&nbsp;&nbsp;&nbsp; Gastroparesis

7.8&nbsp;&nbsp;&nbsp; Depression

7.9&nbsp;&nbsp;&nbsp; Dystonia

7.10&nbsp;&nbsp;&nbsp; Other applications

Chapter 8&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By End Use, 2021 - 2034 ($ Mn)

8.1&nbsp;&nbsp;&nbsp; Key trends

8.2&nbsp;&nbsp;&nbsp; Hospitals

8.3&nbsp;&nbsp;&nbsp; Ambulatory surgery centers

8.4&nbsp;&nbsp;&nbsp; Specialty clinics

8.5&nbsp;&nbsp;&nbsp; Other end users

Chapter 9&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Region, 2021 - 2034 ($ Mn)

9.1&nbsp;&nbsp;&nbsp; Key trends

9.2&nbsp;&nbsp;&nbsp; North America

1.1.1&nbsp;&nbsp;&nbsp; U.S.

1.1.2&nbsp;&nbsp;&nbsp; Canada

9.3&nbsp;&nbsp;&nbsp; Europe

1.1.3&nbsp;&nbsp;&nbsp; Germany

1.1.4&nbsp;&nbsp;&nbsp; UK

1.1.5&nbsp;&nbsp;&nbsp; France

1.1.6&nbsp;&nbsp;&nbsp; Spain

1.1.7&nbsp;&nbsp;&nbsp; Italy

1.1.8&nbsp;&nbsp;&nbsp; Netherlands

9.4&nbsp;&nbsp;&nbsp; Asia Pacific

1.1.9&nbsp;&nbsp;&nbsp; China

1.1.10&nbsp;&nbsp;&nbsp;Japan

1.1.11&nbsp;&nbsp;&nbsp;India

1.1.12&nbsp;&nbsp;&nbsp;Australia

1.1.13&nbsp;&nbsp;&nbsp;South Korea

9.5&nbsp;&nbsp;&nbsp; Latin America

1.1.14&nbsp;&nbsp;&nbsp;Brazil

1.1.15&nbsp;&nbsp;&nbsp;Mexico

1.1.16&nbsp;&nbsp;&nbsp;Argentina

9.6&nbsp;&nbsp;&nbsp; Middle East and Africa

1.1.17&nbsp;&nbsp;&nbsp;South Africa

1.1.18&nbsp;&nbsp;&nbsp;Saudi Arabia

1.1.19&nbsp;&nbsp;&nbsp;UAE

Chapter 10&nbsp;&nbsp;&nbsp;Company Profiles

10.1&nbsp;&nbsp;&nbsp; Abbott Laboratories

10.2&nbsp;&nbsp;&nbsp; Aleva Neurotherapeutics

10.3&nbsp;&nbsp;&nbsp; BioControl Medical

10.4&nbsp;&nbsp;&nbsp; Boston Scientific

10.5&nbsp;&nbsp;&nbsp; ElectroCore

10.6&nbsp;&nbsp;&nbsp; Endostim

10.7&nbsp;&nbsp;&nbsp; Helbling Holding

10.8&nbsp;&nbsp;&nbsp; Innovative Health Solutions

10.9&nbsp;&nbsp;&nbsp; Laborie

10.10&nbsp;&nbsp;&nbsp;LivaNova

10.11&nbsp;&nbsp;&nbsp;Medtronic

10.12&nbsp;&nbsp;&nbsp;MicroTransponder

10.13&nbsp;&nbsp;&nbsp;Neuronetics

10.14&nbsp;&nbsp;&nbsp;Parasym

10.15&nbsp;&nbsp;&nbsp;RS Medical

10.16&nbsp;&nbsp;&nbsp;Synapse Biomedical

10.17&nbsp;&nbsp;&nbsp;tVNS Technologies (Cerbomed) 
&nbsp;

Neurostimulation Devices Market

Get a free sample of this report